Effect of chloride channel blockers on anti-IgE-stimulated histamine and IL-4/IL-13 release from human basophils.
Plath
K E
KE
Department of Dermatology, Medical University of Lübeck, Germany.
Grabbe
J
J
Strenzke
N
N
Wolff
H H
HH
Gibbs
B F
BF
D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology; D001491:Basophils / Q000187:drug effects / Q000502:physiology*; D002034:Bumetanide / Q000494:pharmacology; D018118:Chloride Channels / Q000037:antagonists & inhibitors* / Q000502:physiology; D004232:Diuretics / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007073:Immunoglobulin E / Q000502:physiology; D018793:Interleukin-13 / Q000378:metabolism*; D015847:Interleukin-4 / Q000378:metabolism*
D018118:Chloride Channels; D004232:Diuretics; D018793:Interleukin-13; D002034:Bumetanide; D015847:Interleukin-4; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; D007073:Immunoglobulin E; D005665:Furosemide; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid